Overview
Overarching mission
Spread the use and impact of JMP products far and wide within the Science and Engineering communities at Novozymes.
|
|---|
Three year revenue and use profile
User count
2017: 1130 JMP 5 JMP Pro
2018: 1147 JMP 5 JMP Pro
2019: 1163 JMP 11 JMP Pro
|
Community membership
2017: 201
2018: 271
2019: 295
2020: 357 (06/2020)
|
STIPS enrollment
2018: 7
2019:60
2020: 95 as of June 29, 2020 Current data here
Total all years: 162
|
TSR
2017: $380,074
2018: $422,039
2019: $337,586
|
|
Customer Care
JMP days planned/executed
Engagement score (when available):
|
Account business profile
2019 Revenue: $477,702,336
Cost of Revenue:
Total Employees: 6125
# Engineers/Scientists:
Quick Ratio: .76
D/E Ratio: .23
Operating Margin: 21.08
Profit Margin: 21.08
|
Training Programs
Statistics/Analytics:
JMP: Ongoing engagement with SAS Edu for training in California. Minimal access to e-learning and live web from SAS Edu. On-site in 2018 with North Carolina group.
Other:
|
Technical Value
Departments using JMP: Biofuels, Microbe Research, Bioag
Value received: Product creation (enzymes and microbes), manufacturing and process development, fermentation,
How do they use it? Data Exploration, Statistics, DOE, Modeling, Data Mining
|
Sales opportunities
JMP Live
|
Account Info
Legal name: Novozymes A/S
Common name: Novozymes
Email domains: @novozymes.com
JMP License Info
TSR: - 2018-
Site Location:
Contract #93011 (Bagsværd, Denmark)
Sites: Supplement 7
115936 – JMP Windows Desktop – 1163 TOTUSERS
861619 – JMP Macintosh – 0 TOTUSERS
854816 – JMP Pro Windows Desktop – 11 TOTUSERS
Nonstandard Items:
Multi-national usage
Allowed Countries:
JMP Pro
Country
|
Initial User Count
|
Denmark
|
2
|
USA
|
9
|
Total User Baseline
|
11
|
JMP
Country
|
Initial User Count
|
Denmark
|
465
|
US
|
394
|
China
|
95
|
India
|
76
|
Brazil
|
44
|
Canada
|
32
|
Japan
|
24
|
Malaysia
|
12
|
Switzerland
|
4
|
Argentina
|
4
|
UK
|
3
|
South Africa
|
2
|
Germany
|
2
|
Spain
|
2
|
Mexico
|
1
|
Belgium
|
1
|
Australia
|
1
|
Turkey
|
1
|
Total User Baseline
|
1163
|
Major sites with JMP users
Site/Location
|
Country
|
Number of Users
|
Danish Headquarters, Bagsværd
|
Denmark
|
465
|
Novozymes North America, San Francisco, CA
|
USA
|
394
|
Novozymes China, Tianjini
|
China
|
95
|
Budget
FY Starts
Internal chargeback process for JMP licenses
When budget for next year’s renewal?
Who manages this process?
Contacts
Champions
Americas
Name
|
Location
|
Title/Role
|
Johnny Pham
|
Davis, CA
|
Scientist
|
Jennifer Petitte
|
Durham, NC
|
Senior Research Associate
|
Victor Guadalupe
|
Araucaria, Brazil
|
R&D Group Leader
|
Europe
Name
|
Location
|
Title/Role
|
Lene Cesar
|
Bagsværd, Denmark
|
Science Manager
|
Dr. Marianne Toft
|
Bagsværd, Denmark
|
Senior Statistician
|
Katrine Skeby
|
Bagsværd, Denmark
|
Data Scientist
|
Asia
Name
|
Location
|
Title/Role
|
Lingyu Li
|
Beijing, China
|
|
License Administrator (SAS rep in GIDB), tenure as SAS rep:
JMP
Function
|
Name
|
Contact
|
CRN: SAS Contract Representative
|
Peter Lindstrøm Madsen
|
Krogshøjvej 36, Bagsværd, 2880, +45 44 42 58 33, plma@novozymes.com
|
REP: SAS Representative (Primary)
TRN: Training Coordinator
|
Jesper Spotteck
|
Vadstrupvej 39 (bygn 7DS), Bagsværd, 2880, +45 30 77 32 56, jesp@novozymes.com
|
INV: Invoice Contact
|
Ali Imran
|
Krogshøjvej 36, Bagsværd, 2880, +45 30 77 21 73, aira@novozymes.com
|
Purchasing
Jesper Spotteck is our main contact. Ali Imran is Jesper’s manager who is involved in discussions about the license agreement and decisions that require more time or money.
Training
Americas
Europe
Luise Cederkvist & Morten Hykkelbjerg have taken over his role as internal consultants and trainers in statistics at Novozymes. Morton Hykkelbjerg left Novozymes in March 2020.
07/2019 Inquiry about Training possibilities in Denmark (DOE)
Karine Skeby introduced Johan Pelck Olsen (Scientist) – seeking DOE training for 10-20 scientist.
Update 07/15/2019) Sarah Springer (SAS Education) followed up – Novozymes/Johan are currently reviewing options
JMP related Training Programs
STIPS
Executive sponsors
EBI´s/ Decider:
The responsibility for managing the licenses and the agreements has been taken over by Novozymes’ IT department. Jesper Spotteck is our main contact and Ali Imran is Jesper’s manager who is involved in discussions about the license agreement and decisions that require more time or money.
Power Users
Lene Bjørg Cesar: Science Manager, Statistician
Marianne Toft used to lead the work with JMP at Novozymes. She had worked as an Application Specialist for the Swedish JMP competitor Umetrics where she trained and consulted companies in Data Analysis before she joined Novozymes in 2009. She grew the number of users to over thousand in 8 years. She also had the technical responsibility for JMP at Novozymes and handled licenses and agreements.
Software Deployment
Version of JMP currently used: JMP 15
Push/pull – how does it get deployed, repackage?:
License update process:
Value of JMP
Departments/divisions using JMP
The first one is R&D. Novozymes has big databases full of information about their different enzyme and microbe molecules and their different qualities. They use this information to develop new enzymes and microbes with the help of JMP. JMP can for example tell them how to modify a molecule to make it more efficient or cheaper to produce.
The second big field is manufacturing and process development. Enzymes and microbes are biological products. Almost all biological products are produced in the same way: First comes fermentation where you grow the cells you need to produce the biological substance. Then you purify the biomass that you have fermented. Biological processes are often more complex than chemical processes since the biological material is more difficult to control. The processes also take place in tanks where you can’t do much to control them. You can only measure a few variables like temperature, pH, glucose, oxygen etc and then tweak these to improve yield or quality. But to fully understand what is happening, data analysis is essential and therefore JMP is used more and more at Novozymes as well as other companies who work with bioproduction.
Discovery Papers/Posters
Optimisation and CV Estimation of a Plate Count Assay using JMP
Paper: 2015, Europe (Brussels)
Marianne Toft, Statistician, Novozymes
Using Definitive Screening Design to Optimize Recovery Pre-Treatment of Enzymes
Poster: 2015, Europe (Brussels)
Sandra C. K. Carlsen, Optimisation Scientist, Novozymes
Data Infrastructure
They are building a Data Lake to have one source of truth and all data in one place. Novozymes is gathering all their molecule and process databases in what they call a “Data Lake”, a database for databases one could say
Analytic Tool/Competitive Landscape
Tableau - there is a customer success story on Tablesu website. Title:
Biotechnology company, Novozymes empowers sales teams with mobile dashboards & cuts reporting time by 90%
Strategy
Notes on Technical Engagement
Activity
- 12.02.2019 Intro Call, hand off from Nick Vacca, CA, Dara Hammond
- JMP Pro Thoughts – While you’re currently a JMP Pro user, very few are. You believe the goal of Novozymes is to have one JMP Pro power user at each “site”. Globally, there are about 20-25 sites, and in the US you mentioned about 5. Your team evaluated JMP Pro as there is a 3-year campaign for R&D site to do digitalization, and to analyze, understand, and model that data. [You’d simplified that for my sake so if more detail would be helpful, dive right in!] You felt this is a 1-2 year timeframe to better understand how JMP Pro can impact this campaign directly.
- Weather Project – You worked with Don McCormack to better understand the impact of noise, specifically weather noise, and to how JMP Pro’s functional data explorer may improve the data analysis. Jennifer also worked on this and has a pretty solid proof of concept. I spoke with Don this morning and understand you’ll speak next week to get an update on the progress and path forward.
- Brazil – Vanessa in Brazil may have a more immediate need for functional data explorer and how it can be implemented to better understand and improve fermentation yield. Let us know how we can assist.
- JMP Genomics – There’s interest in genome visualization but again, your opinion is you’re about 1-2 years out from genome-wide analysis and exploration. We’ll keep in touch on this.
- DOE + Machine Learning – I mentioned to Don your question around DOE and Machine Learning. He’s prepared to discuss that next week and get more information on the use case you have in mind.
- 10.07.2019 Call Sao Paulo – Brazi, Victor, Christy Spain, Laura Higgins
- Learnings: Biorefining – second gen ethanol (Biofuels)
- 20 people in R&D analysis
- Power analysis to data analysis – conrol vs treatment (6 month time frame)
- Never had anyone come from JMP/SAS. Did have internal people come down. Jasper Freemon? Did training. Who is this? 4 years ago. Victor wasn’t there for this.
- Biorefining and feed applications.
- Robert Osborne. Group leader.
- Corn ethanol.
- 2 people use it a lot like DOE design. Most people use it for simple analysis.
- Users scientists – proficient in English so ok. Associates not so much.
- TS – more challenge – located at customer sites.
- 14.3 version JMP.
- Some people still on 12 (past version).
- Sounds like they are using STIPS – encouraged from Denmark
- Explore results
- ++Experiments trying to find the best blend for different activities. Multi Y. play with different sugar, corn etc. biomass bases. Different compositions of each. Make a cocktail for each biomass that works, is efficient and low cost for fermentable sugar. Best Blend. Cost effective. Dose, etc. give to customer. US focused on one thing.
- ++ Grabbing large sets of data from industrial customers – find conclusion if the product works on the industrial scale. Look at data for sources for error, outliers, data quality etc. Data = industrial trial sugar cane – temp, process stages, 100 columns, different states of the process. Raw material entry to output of ethanol. 3 data points per day, 30 days, 90 days. Control vs. treatment. 2-3 reps. Highest validation level you can reach. Usually just one treatment (enzyme vs. no enzyme). Or Enzyme vs competitive enzyme. Product launch – enzyme vs. no enzyme.
- Stat team in Denmark – work with them some. Get advice from them.
